Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Universitätsprofessor/in, Klinik für Thorax- und Kardiovaskuläre Chirurgie
Aktuelle Veranstaltungen
-
WiSe 2025
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
-
SoSe 2024
-
WiSe 2023
-
SoSe 2023
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE)In: International Journal of Cancer, Jg. 156, 2025, Nr. 1, S. 154 – 163DOI (Open Access)
-
Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatmentIn: Radiation Oncology, Jg. 17, 2022, Nr. 1, 126DOI, Online Volltext (Open Access)
-
Significantly favourable outcome for patients with non-small-cell lung cancer stage IIIA/IIIB and single-station persistent N2 (skip or additionally N1) disease after multimodality treatmentIn: European Journal of Cardio-Thoracic Surgery, Jg. 61, 2022, Nr. 2, S. 269 – 276DOI (Open Access)
-
Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cmIn: Lung Cancer, Jg. 172, 2022, S. 108 – 116DOI (Open Access)
-
Potential Prognostic Value of Preoperative Leukocyte Count, Lactate Dehydrogenase and C-Reactive Protein in Thymic Epithelial TumorsIn: Pathology & Oncology Research, Jg. 27, 2021, S. 629993DOI, Online Volltext (Open Access)
-
Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive ChemoradiotherapyIn: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 12, S. 1684 – 1691DOI, Online Volltext (Open Access)
-
Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment : Only few risks left to improveIn: European Journal of Cancer (EJC), Jg. 138, 2020, S. 156 – 168
-
Cerebral Recurrence after trimodal Therapy of Patients with locally advanced NSCLC - Prognostic Factors and prognostic ImportanceIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 195, 2019, Nr. Suppl. 1, S. S66 – S67
-
Effectiveness of Robotic Lobectomy—Outcome and Learning Curve in a High Volume CenterIn: The Thoracic and Cardiovascular Surgeon, Jg. 67, 2019, Nr. 7, S. 573 – 577
-
Lymph Node Involvement and the Surgical Treatment of Thymic Epithelial and Neuroendocrine CarcinomaIn: The Annals of Thoracic Surgery, Jg. 107, 2019, Nr. 6, S. 1632 – 1638DOI (Open Access)
-
Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system)In: Lung Cancer, Jg. 138, 2019, S. 19 – 26
-
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules : analysis of the ESPATUE randomized phase 3 trialIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 46, 2019, Nr. 7, S. 1439 – 1447
-
P1.14-21 Circulating Biomarkers in Thymic Epithelial TumorsIn: Journal of Thoracic Oncology, Jg. 13, 2018, Nr. 10, S. S607DOI (Open Access)
-
Pre-therapeutic metabolic Tumor Volume (MTV) in (18) F-FDG-PET/CT as a prognostic Factor in Patients with Stage IIIA-IIIB NSCLC before Trimodal Therapy or definitive Chemoradiotherapy - Results of Phase 3 StudyIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 194, 2018, Nr. Suppl.1, S. S41 – S42DOI (Open Access)
-
Pretreatment metabolic volume in PET : Prognostic in lung cancer? German ESPATUE randomised phase3trialIn: Radiotherapy and Oncology (The Green Journal), Jg. 127, 2018, Nr. Suppl.1, S. S253 – S254DOI (Open Access)
-
Definitive radiochemotherapy versus surgery within multimodality treatment in stage III non-small cell lung cancer (NSCLC) - a cumulative meta-analysis of the randomized evidenceIn: OncoTarget, Jg. 8, 2017, Nr. 25, S. 41670 – 41678DOI (Open Access)
-
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer : secondary analysis of a randomized trialIn: Annals of Oncology, Jg. 28, 2017, Nr. 5, S. 1084 – 1089DOI (Open Access)
-
Is There a Role for Surgery in SCLC?In: Journal of Thoracic Oncology, Jg. 12, 2017, Nr. Suppl. 1, S. S64 – S65
-
Prognostic Significance of Mean Lung Dose (MLD) in the dose-enhanced Radiochemotherapy of Local Advanced NSCLC - Analysis of ESPATU's Definitive Radiochemotherapy ArmIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 193, 2017, Nr. 1, S. 20
-
Pulmonary metastasectomy for sarcoma-Essen experienceIn: Journal of Thoracic Disease, Jg. 9, 2017, S. S1278 – S1281DOI (Open Access)
-
Resection of the tracheobronchial bifurcation with complete preservation of lung parenchymaIn: The Annals of Thoracic Surgery, Jg. 104, 2017, Nr. 5, S. 1741 – 1747
-
The influence of type of anesthesia, perioperative pain, and preoperative health status on chronic pain six months after thoracotomy-A prospective cohort studyIn: Pain Medicine, Jg. 18, 2017, Nr. 11, S. 2208 – 2213
-
A Single-Institution Analysis of the Surgical Management of Pulmonary Large Cell Neuroendocrine CarcinomasIn: The Annals of Thoracic Surgery, Jg. 101, 2016, Nr. 5, S. 1909 – 1914
-
An infrared spectroscopic blood test for non-small cell lung carcinoma and subtyping into pulmonary squamous cell carcinoma or adenocarcinomaIn: Biomedical Spectroscopy and Imaging, Jg. 5, 2016, Nr. 2, S. 129 – 144
-
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patientsIn: Journal of Cancer Research and Clinical Oncology, Jg. 142, 2016, Nr. 4, S. 795 – 805
-
Short- and Mid-Term Changes in Lung Function after Bilateral Pulmonary MetastasectomyIn: The Thoracic and Cardiovascular Surgeon, Jg. 64, 2016, Nr. 2, S. 139 – 145
-
Standardized Uptake Decrease on [18F]-Fluorodeoxyglucose Positron Emission Tomography After Neoadjuvant Chemotherapy Is a Prognostic Classifier for Long-Term Outcome After Multimodality Treatment : Secondary Analysis of a Randomized Trial for Resectable Stage IIIA/B Non-Small-Cell Lung CancerIn: Journal of Clinical Oncology (JCO), Jg. 34, 2016, Nr. 21, S. 2526 – 2533
-
Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)In: Journal of Thoracic Oncology, Jg. 11, 2016, Nr. 1, S. 85 – 93DOI (Open Access)
-
Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomyIn: Journal of Thoracic Disease, Jg. 7, 2015, Nr. 3, S. 264 – 272
-
Controlled-Release Oxycodone as "Gold Standard" for Postoperative Pain Therapy in Patients Undergoing Video-Assisted Thoracic Surgery or Thoracoscopy : A Retrospective Evaluation of 788 CasesIn: The Thoracic and Cardiovascular Surgeon, Jg. 63, 2015, Nr. 6, S. 510 – 513
-
HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomasIn: Lung Cancer, Jg. 88, 2015, Nr. 1, S. 34 – 41
-
Marker-free automated histopathological annotation of lung tumour subtypes by FTIR imagingIn: The Analyst / Royal Society of Chemistry (RSC) (Hrsg.), Jg. 140, 2015, Nr. 7, S. 2114 – 2120DOI (Open Access)
-
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)In: Journal of Clinical Oncology (JCO), Jg. 33, 2015, Nr. 35, S. 4194 – 4201
-
Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factorsIn: BMC Cancer, Jg. 15, 2015, Nr. 1, S. 363DOI (Open Access)
-
Pulmonary manifestation of a condition resembling Kasabach–Merritt syndrome in a woman with abdominal angiomatosis associated with consumptive coagulopathy – surgical management : a case reportIn: Journal of Medical Case Reports, Jg. 9, 2015, S. 107DOI (Open Access)
-
Staging of lung cancer : the role of noninvasive, minimally invasive and invasive techniquesIn: European Respiratory Journal (ERJ), Jg. 46, 2015, Nr. 2, S. 521 – 531DOI (Open Access)
-
Tracheaverletzungen, Insuffizienz von Bronchusstumpf/-anastomose und Rekurrensparese : Management der Komplikationen in der ThoraxchirurgieIn: Der Chirurg, Jg. 86, 2015, Nr. 5, S. 410 – 418
-
Einschränkung der Thrombozytenfunktion 11 Tage nach Clopidogrel-Gabe : Fallbericht eines Patienten mit Tako-Tsubo-Ereignis und PeriduralanalgesieIn: Anästhesiologie & Intensivmedizin, Jg. 55, 2014, Nr. 3, S. 125 – 128
-
Extended resections for lung cancer with invasion of the chest wall, superior sulcus and spineIn: Der Onkologe, Jg. 20, 2014, Nr. 10, S. 969 – 981
-
Gene expression analysis of the 26S proteasome subunit PSMB4 reveals significant upregulation, different expression and association with proliferation in human pulmonary neuroendocrine tumoursIn: Journal of Cancer, Jg. 5, 2014, Nr. 8, S. 646 – 654DOI (Open Access)
-
Management of a Chest-Wall Soft-Tissue Tumor Caused by an Infection with the Larval Tapeworm Pathogen Taenia crassicepsIn: American Journal of Tropical Medicine and Hygiene, Jg. 91, 2014, Nr. 3, S. 541 – 543DOI, Online Volltext (Open Access)
-
Minimal incidence of chronic and neuropathic postthoracotomy pain after anteroaxillary thoracotomy with consequent systemic pain therapyIn: European Journal of Anaesthesiology EJA, Jg. 31, 2014, Nr. 9, S. 508 – 511
-
Modified Clagett Procedure Is Effective for Methicillin-Resistant Staphylococcus aureus Postpneumonectomy Empyema : A Case ReportIn: World Journal of Oncology, Jg. 5, 2014, Nr. 4, S. 178 – 180DOI (Open Access)
-
Neuroendocrine Tumors of the Lung : The Role of Surgery in Small Cell Lung CancerIn: Thoracic Surgery Clinics, Jg. 24, 2014, Nr. 3, S. 313 – 326
-
Phase III study of surgery (S) versus definitive concurrent chemoradiotherapy boost (def ccCRTx-BOx) in patients (pts) with operable (OP+) stage IIIA(N2)/selected IIIb (sel IIIB) non-small cell lung cancer (NSCLC) following induction (IND) chemotherapy (CTx) and concurrent CRTx (ESPATUE)In: Journal of Clinical Oncology (JCO), Jg. 32, 2014, Nr. 15 Suppl., S. 7510
-
Resection of a Giant Neuroblastoma Misdiagnosed as Atypical Mediastinal CarcinoidIn: Journal of Thoracic Oncology, Jg. 9, 2014, Nr. 1, S. 132 – 134
-
Surgery of Primary Lung Cancer with Oligometastatic M1b Synchronous Single Brain Metastasis : Analysis of 37 CasesIn: The Thoracic and Cardiovascular Surgeon, Jg. 62, 2014, Nr. 7, S. 612 – 615
-
The impact of epidural analgesia compared to systemic opioid-based analgesia with regard to length of hospital stay and recovery of bowel function : retrospective evaluation of 1555 patients undergoing thoracotomyIn: Journal of Cardiothoracic Surgery, Jg. 9, 2014, S. 175DOI (Open Access)
-
Thoracic staging in lung cancer : prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CTIn: Journal of Nuclear Medicine (JNM), Jg. 55, 2014, Nr. 3, S. 373 – 378DOI (Open Access)
-
Thymoma and thymic carcinoma : a multivariate analysis of prognostic factors in 220 patientsIn: Journal of Thoracic Oncology, Jg. 9, 2014, Nr. 10, Suppl. 4, S. S241 – S242
-
10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)—A multicenter phase-II trial (CISTAXOL)In: Lung Cancer, Jg. 82, 2013, Nr. 1, S. 83 – 89
-
Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer : Markedly higher rate of pathologic complete remissions than with conventional fractionationIn: European Journal of Cancer (EJC), Jg. 49, 2013, Nr. 9, S. 2107 – 2115
-
Epidural analgesia is not superior to systemic postoperative analgesia with regard to preventing chronic or neuropathic pain after thoracotomyIn: Journal of Cardiothoracic Surgery, Jg. 8, 2013, Nr. 1, S. 127
-
Experimental Respiratory Syncytial Virus Infection of Human Peribronchial Gland Cells In VitroIn: Ultrastructural Pathology, Jg. 37, 2013, Nr. 5, S. 312 – 317
-
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer CenterIn: European Journal of Cancer (EJC), Jg. 49, 2013, Nr. 15, S. 3076 – 3082
-
Free soluble HLA-G molecules but not exosome-derived soluble HLA-G molecules are of prognostic relevance in lung cancer patientsIn: Tissue Antigens, Jg. 81, 2013, Nr. 5, S. 282 – 283
-
Glanduläres Papillom des rechten Hauptbronchus : Nachweis einer Exon-2-Mutation des KRAS-Gens (c.35G>A)In: Der Pathologe, Jg. 34, 2013, Nr. 4, S. 338 – 342
-
Midterm changes in quality of life : A prospective evaluation after open pulmonary metastasectomyIn: The Annals of Thoracic Surgery, Jg. 95, 2013, Nr. 3, S. 1006 – 1011
-
Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine : The TREAT studyIn: Annals of Oncology, Jg. 24, 2013, Nr. 4, S. 986 – 992
-
Changes in Lung Function Parameters After Wedge Resections : A Prospective Evaluation of Patients Undergoing MetastasectomyIn: Chest, Jg. 141, 2012, Nr. 6, S. 1482 – 1489
-
Distribution pattern of metastases and their associations with survival of malignant pleural mesothelioma patients undergoing different treatment modalitiesIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 140
-
Erste Sicherheitsanalyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie : Keine Signale für unerwartete Adverse Events/ToxizitätenIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 188, 2012, Nr. Suppl. 1, S. 34
-
Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural MesotheliomaIn: Journal of Thoracic Oncology, Jg. 7, 2012, Nr. 9, S. 1440 – 1448DOI (Open Access)
-
Growth patterns of lung metastases from sarcoma : prognostic and surgical implications from histologyIn: Interactive Cardiovascular and Thoracic Surgery, Jg. 15, 2012, Nr. 4, S. 612 – 617
-
Improvement of histopathological Remission after neoadjuvant chemotherapy of accelerated hyperfractionation compared to conventional fractionation in locally advanced NSCLC (stage III)In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 188, 2012, Nr. Suppl. 1, S. 96 – 96
-
Lung segment geometry study : simulation of largest possible tumours that fit into bronchopulmonary segmentsIn: The Thoracic and Cardiovascular Surgeon, Jg. 60, 2012, Nr. 2, S. 93 – 100
-
Risk factors for impaired lung function after pulmonary metastasectomy : a prospective observational study of 117 casesIn: European Journal of Cardio-Thoracic Surgery, Jg. 42, 2012, Nr. 2, S. e22 – e27
-
Staging des Lungenkarzinoms : Welche Rolle spielt die Mediastinoskopie heute?In: Zentralblatt für Chirurgie, Jg. 137, 2012, Nr. 3, S. 242 – 247
-
State of the Art : Stage III NSCLCIn: Journal of Thoracic Oncology, Jg. 7, 2012, Nr. Suppl. 6, S. 16
-
Who should be considered for surgery for stage III disease and why?In: Annals of Oncology, Jg. 23, 2012, Nr. Suppl. 9, S. 49
-
Βv-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancerIn: British Journal of Cancer (BJC), Jg. 107, 2012, Nr. 5, S. 823 – 830DOI (Open Access)
-
10-year long-term survival (LTS) of induction (IND) chemotherapy (CTX) with three cycles cisplatin(P)/paclitaxel(T) followed by concurrent (CC) chemoradiation (CTX/RTX) P/Etoposide (ETO)/45 GY (1.5 GY BID) plus surgery (S) - A multicenter phase-II trial (Cistaxol)In: Journal of Thoracic Oncology, Jg. 6, 2011, Nr. 6, Suppl. 2, S. 494
-
15-Year (very) long-term survival (VLTS) and competing risks (CR) analysis of induction (IND) chemotherapy (CTX) with three cycles cisplatin (P) / etoposide (E) followed by concurrent (CC) chemoradiation (CTX/RTX) PE/45 GY (1.5 GY BID) pkus surgery (S) = TRIMIn: Journal of Thoracic Oncology, Jg. 6, 2011, Nr. 6, Suppl. 2, S.S 492 - S493
-
A new technique for complete intraluminal repair of iatrogenic posterior tracheal lacerationsIn: Interactive Cardiovascular and Thoracic Surgery, Jg. 12, 2011, Nr. 1, S. 6 – 9
-
Growth patterns of lung metastases from sarcomasIn: Virchows Archiv, Jg. 459, 2011, Nr. 2, S. 213 – 219
-
Long-term survival (LTS) and competing risks within a prospective multi center German randomized trial comparing induction chemotherapy (CTx) followed by concurrent (cc) chemoradiation (CTx/RTx) plus surgery (SURG; TRIMODALITY) supplemented by PCI versus local treatment (Tx) alone (SURG + RTx) in operable IIIA NSCLC.In: Journal of Clinical Oncology (JCO), Jg. 29, 2011, Nr. 15_suppl, S. 7042
-
Long-term survival (LTS) and competing risks within a prospective multicenter german randomized trial comparing induction (IND) chemotherapy (CTX) followed by concurrent (CC) chemoradiation (CTX/RTX) plus surgery (S) (= Trimodality) supplemented by PCI VEIn: Journal of Thoracic Oncology, Jg. 6, 2011, Nr. 6, Suppl. 2, S. 495
-
Long-term survival (S) of induction chemotherapy (CTx) with three cycles cisplatin (cis)/paclitaxel (pac) followed by concurrent (cc) chemoradiation (CTx/RTx) cis/etoposide (eto) and 45 Gy (1.5 Gy bid) plus surgery (SURG) : Phase II results (CISTAXOL)In: Journal of Clinical Oncology (JCO), Jg. 29, 2011, Nr. 15_suppl, S. 7047
-
Long-term survival results and prognostic factor analysis of two consecutive trimodality Phase-II trials in stage IIIA(N2) and selected stage IIIB non-small-cell lung cancer (NSCLC)In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 187, 2011, Nr. Suppl. 1, S. 68 – 69
-
Prevention, diagnosis, therapy, and follow-up of lung cancer : interdisciplinary guideline of the German respiratory society and the German cancer society abridged versionIn: Pneumologie, Jg. 65, 2011, Nr. 8, S. e51 – e75
-
Randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed (CPx) versus cisplatin and vinorelbine (CVb) : TREATIn: Journal of Clinical Oncology (JCO), Jg. 29, 2011, Nr. 15_suppl, S. 7002
-
Safety distance in the resection of colorectal lung metastases : A prospective evaluation of satellite tumor cells with immunohistochemistryIn: The Journal of Thoracic and Cardiovascular Surgery, Jg. 141, 2011, Nr. 5, S. 1218 – 1222DOI (Open Access)
-
A new endoscopic technique for intraluminal repair of posterior tracheal lacerationIn: The Annals of Thoracic Surgery, Jg. 90, 2010, Nr. 2, S. 686 – 688
-
Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trialIn: International Journal of Radiation Oncology, Biology, Physics, Jg. 76, 2010, Nr. 3, S. 809 – 815
-
Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancerIn: The Thoracic and Cardiovascular Surgeon, Jg. 139, 2010, Nr. 6, S. 1424 – 1430DOI (Open Access)
-
Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patientsIn: Human Immunology, Jg. 71, 2010, Nr. 5, S. 489 – 495
-
Prävention, Diagnostik, Therapie und Nachsorge des LungenkarzinomsIn: Pneumologie, Jg. 64, 2010, Nr. Suppl. 2, S. e1 – e164
-
Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancerIn: Oncology, Jg. 73, 2008, Nr. 5-6, S. 316 – 323
-
Pulmonary metastases of breast cancer : When is resection indicated?In: European Journal of Cardio-Thoracic Surgery, Jg. 34, 2008, Nr. 6, S. 1228 – 1234DOI (Open Access)
-
Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumourIn: European Respiratory Journal, Jg. 29, 2007, Nr. 1, S. 117 – 127DOI (Open Access)
-
Solitary pulmonary nodule with growth and constrast enhancement at CT : Inflammatory pseudotumour as an unusual benign causeIn: British Journal of Radiology, Jg. 79, 2006, Nr. 937, S. 76 – 78
-
Value of ¹⁸F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapyIn: Clinical Cancer Research, Jg. 12, 2006, Nr. 1, S. 97 – 106
-
Langzeitüberleben und konkurrierende Risiken von Patienten einer randomisierten Studie zur defnitiven vs. neoadjuvanten Radiochemotherapie + Resektion mit einem nach der Induktion resektablen NSCLC im Stadium IIIIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S7 – S8DOI (Open Access)
-
Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLCIn: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 17, 2022, Nr. 9, S. 65
-
Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer : Secondary Analysis of a Randomized Phase 3 Trial
61st Annual Meeting of the American Society for Radiation Oncology ; September 15-18, 2019, Chicago, IL, USA,In: International Journal of Radiation Oncology, Biology, Physics. New York: Elsevier, Jg. 105, 2019, Nr. 1, Supplement, S. S146 – S147DOI (Open Access) -
Long-term Survival (LT-S) and Survivorship Program (SS-P) of Lung Cancer (LC) Patients (Pts) - B : Implications for Follow-up (F-up) and Surveillance (SV)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 109 – 110DOI (Open Access) -
Long-term Survival(LTS) and Survivorship Program(SS-P) of Lung Cancer(LC) Patients(Pts). Investigations(Invest) on LT-toxicities(Tox) and late morbidities(Morb)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 108DOI (Open Access) -
18 F-FDG-Response als prognostischer Faktor für das progressionsfreie Überleben bei der Behandlung von lokal fortgeschrittenen, nichtkleinzelligen Lungenkarzinonem : Trimodale Therapie vs. definitive Radiochemotherapie – Monozentrische Ergebnisse
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 191, 2015, Nr. Suppl.1, S. S21 – S22 -
Hirnmetastasen bei Patienten mit lokal fortgeschrittenem NSCLC nach multimodaler kurativer Therapie in einem randomisierten Protokoll : prognostische Faktoren
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 191, 2015, Nr. Suppl. 1, S. 36 – 37 -
Rekursive Partitions-Analyse prognostischer Faktoren für das Langzeit-Überleben nach trimodaler Therapie von Patienten mit lokal fortgeschrittenem NSCLC
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 191, 2015, Nr. Suppl. 1, S. 23 -
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 5, S. 226 – 227 -
Definitive Hyperfractionated Accelerated (AHF) Radiochemotherapy (CRT) Versus Neoadjuvant AHF-CRT and Surgery (S) for Patients (pts) With Operable Stage IIIA(N2)/Selected IIIB Non-small-Cell Lung Cancer (NSCLC) Following Induction Chemotherapy (IND-C) : Results From a Multicenter Phase III Study
56th Annual Meeting of the American Society for Radiation Oncology ; 14-17 September 2014, San Francisco, CA, USA,In: International Journal of Radiation Oncology, Biology, Physics. New York: Elsevier, Jg. 90, 2014, Nr. 1, Supplement, S. S146 – S147 -
Definitive accelerated-hyperfractionated (AHF) Chemoradiotherapy (CRT) vs. neoadjuvant AHF-CRT and Surgery (S) for Patients with operable NSCLC in Stage IIIA(N2)/IIIB after Induction Chemotherapy (IND-C) : Results of a randomized Multicentre Study
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 190, 2014, Nr. Suppl. 1, S. 5 – 6 -
Patients with epidural analgesia stay as long in hospital as patients with initial systemic pain therapy, but are dismissed with higher opioid doses : retrospective evaluation of 1555 patientsIn: European Journal of Anaesthesiology EJA: Lippincott Williams & Wilkins, Jg. 31, 2014, Nr. Suppl. 52, S. 234 – 235
-
Prognostisches Modell für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 190, 2014, Nr. Suppl 1, S. 17 -
Vergleich von pCR und mediastinalem Downstaging als Surrogat- Marker für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion (Trimodalität)
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 190, 2014, Nr. Suppl. 1, S. 17 -
WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 2 – 3 -
Akzeleriert-hyperfraktionierte Radiotherapie (RTx) mit simultaner Chemotherapie (CTx) im neoadjuvanten Konzept bei Stadium-III Lungenkarzinom : signifikant höhere Rate pathologisch kompletter Remissionen (pCR) im Vergleich mit konventioneller Fraktionierung
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 189, 2013, Nr. Suppl. 1, S. 19 -
Compliance-Analyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie : lassen sich Patienten lieber operieren?
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 189, 2013, Nr. Suppl. 1, S. 87 -
Accelerated Hyperfractionated Radiation Therapy Within Trimodality Therapy Concepts for Stage IIIa/b Non-small Cell Lung Cancer : Markedly Higher Rate of Pathologic Complete Remissions Than With Conventionally Fractionated Radiochemotherapy
54th Annual Meeting of the American Society for Radiation Oncology ; 28-31 October 2012, Boston, MA, USA,In: International Journal of Radiation Oncology, Biology, Physics. New York: Elsevier, Jg. 84, 2012, Nr. 3, Supplement, S. S154 -
Competing risks analysis and long-term survival (LTS) of patients (PTS) with locally advanced (LAD) stage III non-small- cell lung cancer (NSCLC) treated on sequential trimodality (TM) trials
14th World Conference on Lung Cancer (WCLC), July 03 - 07, 2011, Amsterdam, The Netherlands,In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 6, 2011, Nr. 6, Suppl. 2, S. S376 – S377 -
Lung volume reduction surgeryIn: Chest surgery / Dienemann, Hendrik; Hoffmann, Hans; Detterbeck, Frank C. (Hrsg.). Heidelberg [u.a.]: Springer, 2015, S. 255 – 262